Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $1.88 billion. The enterprise value is $1.45 billion.
| Market Cap | 1.88B |
| Enterprise Value | 1.45B |
Important Dates
The last earnings date was Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 36.08 million shares outstanding. The number of shares has increased by 25.79% in one year.
| Shares Outstanding | 36.08M |
| Shares Change (YoY) | +25.79% |
| Shares Change (QoQ) | +18.42% |
| Owned by Insiders (%) | 6.36% |
| Owned by Institutions (%) | 103.81% |
| Float | 30.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8,047.94 |
| Forward PS | n/a |
| PB Ratio | 4.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6,212.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.74, with a Debt / Equity ratio of 0.03.
| Current Ratio | 24.74 |
| Quick Ratio | 23.71 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.50% and return on invested capital (ROIC) is -38.35%.
| Return on Equity (ROE) | -45.50% |
| Return on Assets (ROA) | -41.70% |
| Return on Capital (ROIC) | -38.35% |
| Revenue Per Employee | $1,721 |
| Profits Per Employee | -$1.18M |
| Employee Count | 136 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.16% in the last 52 weeks. The beta is 1.32, so KROS's price volatility has been higher than the market average.
| Beta (1Y) | 1.32 |
| 52-Week Price Change | +13.16% |
| 50-Day Moving Average | 60.86 |
| 200-Day Moving Average | 45.44 |
| Relative Strength Index (RSI) | 36.33 |
| Average Volume (30 Days) | 338,498 |
Short Selling Information
The latest short interest is 2.29 million, so 6.34% of the outstanding shares have been sold short.
| Short Interest | 2.29M |
| Short Previous Month | 2.26M |
| Short % of Shares Out | 6.34% |
| Short % of Float | 7.39% |
| Short Ratio (days to cover) | 8.62 |
Income Statement
In the last 12 months, KROS had revenue of $234,000 and -$160.30 million in losses. Loss per share was -$5.15.
| Revenue | 234,000 |
| Gross Profit | 234,000 |
| Operating Income | -179.56M |
| Pretax Income | -160.30M |
| Net Income | -160.30M |
| EBITDA | -158.01M |
| EBIT | -160.30M |
| Loss Per Share | -$5.15 |
Balance Sheet
The company has $443.66 million in cash and $14.20 million in debt, giving a net cash position of $429.45 million or $11.90 per share.
| Cash & Cash Equivalents | 443.66M |
| Total Debt | 14.20M |
| Net Cash | 429.45M |
| Net Cash Per Share | $11.90 |
| Equity / Book Value | 453.95M |
| Book Value Per Share | 12.58 |
| Working Capital | 444.41M |
Cash Flow
In the last 12 months, operating cash flow was -$134.83 million and capital expenditures -$2.35 million, giving a free cash flow of -$137.18 million.
| Operating Cash Flow | -134.83M |
| Capital Expenditures | -2.35M |
| Free Cash Flow | -137.18M |
| FCF Per Share | -$3.84 |
Margins
Gross margin is 100.00%, with operating and profit margins of -76,732.91% and -68,505.13%.
| Gross Margin | 100.00% |
| Operating Margin | -76,732.91% |
| Pretax Margin | -68,505.13% |
| Profit Margin | -68,505.13% |
| EBITDA Margin | -67,524.79% |
| EBIT Margin | -68,505.13% |
| FCF Margin | -58,624.36% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.79% |
| Shareholder Yield | -25.79% |
| Earnings Yield | -8.51% |
| FCF Yield | -7.28% |
Analyst Forecast
The average price target for KROS is $86.00, which is 64.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $86.00 |
| Price Target Difference | 64.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 388.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 34.24 and a Piotroski F-Score of 3.
| Altman Z-Score | 34.24 |
| Piotroski F-Score | 3 |